Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tien-Yuan Wu

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 9, 2020
Real-world prevalence of hepatitis B virus reactivation in cancer patients in TaiwanChi-Hua Chen, Hui-Hsia Hsieh, Tien-Yuan Wu
Medicine|December 10, 2021
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Tzu Chi Medical Journal|August 1, 2022
Computer-aided discovery, design, and investigation of COVID-19 therapeuticsChun-Chun Chang, Hao-Jen Hsu, Tien-Yuan Wu, et al.
Stem Cell Research|July 9, 2013
Genomic imprinting is variably lost during reprogramming of mouse iPS cellsSachiko Takikawa, Chelsea Ray, Xin Wang, et al.
Therapeutic Advances in Drug Safety|June 26, 2023
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
The AAPS Journal|July 12, 2019
A Tangeretin Derivative Inhibits the Growth of Human Prostate Cancer LNCaP Cells by Epigenetically Restoring p21 Gene Expression and Inhibiting Cancer Stem-like Cell ProliferationGuor-Jien Wei, Yen-Hsiang Chao, Yen-Chen Tung, et al.
BMC Cancer|February 14, 2023
Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Integrative Cancer Therapies|June 9, 2023
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective StudyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Biochemical Pharmacology|July 27, 2011
Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylationTin Oo Khor, Ying Huang, Tien-Yuan Wu, et al.
Chemical Research in Toxicology|March 30, 2011
tBHQ-induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1Ka Lung Cheung, Siwang Yu, Zui Pan, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 9, 2020
Real-world prevalence of hepatitis B virus reactivation in cancer patients in TaiwanChi-Hua Chen, Hui-Hsia Hsieh, Tien-Yuan Wu
Medicine|December 10, 2021
Cost-effectiveness and clinical outcomes of intermittent/continuous proton pump inhibitors infusion in high bleeding risk of ulcers: A retrospective observational cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Tzu Chi Medical Journal|August 1, 2022
Computer-aided discovery, design, and investigation of COVID-19 therapeuticsChun-Chun Chang, Hao-Jen Hsu, Tien-Yuan Wu, et al.
Stem Cell Research|July 9, 2013
Genomic imprinting is variably lost during reprogramming of mouse iPS cellsSachiko Takikawa, Chelsea Ray, Xin Wang, et al.
Therapeutic Advances in Drug Safety|June 26, 2023
Survival outcomes of beta-blocker usage in HER2-positive advanced breast cancer patients: a retrospective cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
The AAPS Journal|July 12, 2019
A Tangeretin Derivative Inhibits the Growth of Human Prostate Cancer LNCaP Cells by Epigenetically Restoring p21 Gene Expression and Inhibiting Cancer Stem-like Cell ProliferationGuor-Jien Wei, Yen-Hsiang Chao, Yen-Chen Tung, et al.
BMC Cancer|February 14, 2023
Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort studyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Integrative Cancer Therapies|June 9, 2023
Survival Outcomes of Calcium Channel Blocker Therapy in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Inhibitors: A Retrospective StudyHui-Hsia Hsieh, Tien-Yuan Wu, Chi-Hua Chen, et al.
Biochemical Pharmacology|July 27, 2011
Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylationTin Oo Khor, Ying Huang, Tien-Yuan Wu, et al.
Chemical Research in Toxicology|March 30, 2011
tBHQ-induced HO-1 expression is mediated by calcium through regulation of Nrf2 binding to enhancer and polymerase II to promoter region of HO-1Ka Lung Cheung, Siwang Yu, Zui Pan, et al.
Pageof 5